A Regional Payers' Perspective
of the Explanation of the Italian System from
AIFA to local hospitals

Thomas Schael
CEO AS...
Spending review 2010 (D.L. 78/2010):
Impact of 1,3 billion €

(Source: estimates IMS Health)
A very complex Supply Chain

3
New models for the distribution of pharmaceuticals in Italy
Farmaceutica convenzionata
conventional distribution by local...
The Public Health Authority Province of Naples
“ASL Napoli 2 Nord”
•Over 1 million inhabitants

•32 Cities and the Irlands...
ASL Napoli 2 Nord: 223 privat pharmacies
ASL Napoli 2 Nord: public pharmacies and hospitals
10 Farmacia distrettuale
4 Farmacia ospedaliera
Pharmaceutical spending control project

Project

A.R.Ca.
Logical flow and datawarehouse

Deviation

Analysis
Alert
The people involved

10
Ipertension (C09)
% ddd Losartan 2010 ASL Napoli 2 Nord
ASL Napoli 2 Nord
usage of Losartan in different districts in 2010
Reduction of the pharmceutical spending
ASL Napoli 2 Nord 2010

-€ 20 milioni in 9 months
-€ 40 per citizen per year
Next challenge: Regione Piemonte

Objectives

= 14%

Source: AIFA Rapporto OSMED gennaio-Settembre 2012

- 10% spending on...
Upcoming SlideShare
Loading in …5
×

Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities and Hospitals

1,002 views

Published on

Thomas Schael's presentation on insights and actionables on drug expenditure and the requirements of Italian payers for market access at the Payers' Forum Europe 2013 in Berlin.Thomas Schael discusses Italy’s drug distribution system and explains how he dramatically cut spending on drugs. Schael gives his outlook on the major challenges for drug expenditure in Italy and Europe and offers advice to the pharmaceutical industry on how to work better with authorities.

Published in: Health & Medicine, Business
1 Comment
0 Likes
Statistics
Notes
  • Be the first to like this

No Downloads
Views
Total views
1,002
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
7
Comments
1
Likes
0
Embeds 0
No embeds

No notes for slide

Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities and Hospitals

  1. 1. A Regional Payers' Perspective of the Explanation of the Italian System from AIFA to local hospitals Thomas Schael CEO ASL Magna Grecia Crotone - Commissionar ASL Napoli 2 Nord Coordinator Pharmaclick Punto Salute Advisor Healthcare Reform Regione Piemonte Berlin, October 22nd 2013
  2. 2. Spending review 2010 (D.L. 78/2010): Impact of 1,3 billion € (Source: estimates IMS Health)
  3. 3. A very complex Supply Chain 3
  4. 4. New models for the distribution of pharmaceuticals in Italy Farmaceutica convenzionata conventional distribution by local pharmacies with a reimbursement contract referring to official AIFA prices with a possible discount Distribuzione diretta direct distribution of pharmaceuticals by public health authorities and hospitals bought directly from the producer Distribuzione in nome e per conto distribution of pharmaceuticals by local pharmacies bought directly from the producer by local health authorities paying a fixed service fee for each unit distributed by the pharmacies 4
  5. 5. The Public Health Authority Province of Naples “ASL Napoli 2 Nord” •Over 1 million inhabitants •32 Cities and the Irlands of Ischia and Procida •Territorry of 450 square km •5 public hospitals and 5 private hospitals •4200 employees and 1800 contracted GPs
  6. 6. ASL Napoli 2 Nord: 223 privat pharmacies
  7. 7. ASL Napoli 2 Nord: public pharmacies and hospitals 10 Farmacia distrettuale 4 Farmacia ospedaliera
  8. 8. Pharmaceutical spending control project Project A.R.Ca.
  9. 9. Logical flow and datawarehouse Deviation Analysis Alert
  10. 10. The people involved 10
  11. 11. Ipertension (C09) % ddd Losartan 2010 ASL Napoli 2 Nord
  12. 12. ASL Napoli 2 Nord usage of Losartan in different districts in 2010
  13. 13. Reduction of the pharmceutical spending ASL Napoli 2 Nord 2010 -€ 20 milioni in 9 months -€ 40 per citizen per year
  14. 14. Next challenge: Regione Piemonte Objectives = 14% Source: AIFA Rapporto OSMED gennaio-Settembre 2012 - 10% spending on territorial pharma - 5% spending on hospital pharma Cost Earnings - €96 million Period 2013-2015

×